WINTON GROUP Ltd Cuts Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

WINTON GROUP Ltd cut its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 2.1% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 66,654 shares of the company’s stock after selling 1,403 shares during the period. WINTON GROUP Ltd owned 0.16% of Phibro Animal Health worth $1,118,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. CWM LLC boosted its holdings in Phibro Animal Health by 89.8% in the second quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after acquiring an additional 1,035 shares during the last quarter. Fidelis Capital Partners LLC acquired a new position in shares of Phibro Animal Health in the 1st quarter valued at about $46,000. China Universal Asset Management Co. Ltd. increased its position in Phibro Animal Health by 65.0% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 3,888 shares of the company’s stock worth $50,000 after purchasing an additional 1,531 shares in the last quarter. Quest Partners LLC acquired a new stake in Phibro Animal Health during the 4th quarter worth approximately $56,000. Finally, Summit Securities Group LLC purchased a new position in Phibro Animal Health in the second quarter valued at approximately $83,000. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Trading Up 3.7 %

Shares of PAHC opened at $21.99 on Monday. The company has a debt-to-equity ratio of 1.79, a quick ratio of 1.64 and a current ratio of 2.94. Phibro Animal Health Co. has a one year low of $9.40 and a one year high of $22.31. The stock has a 50-day moving average price of $18.91 and a 200 day moving average price of $16.62. The company has a market capitalization of $890.60 million, a P/E ratio of 68.72, a P/E/G ratio of 1.60 and a beta of 0.52.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Wednesday, September 4th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.18%. The ex-dividend date of this dividend is Wednesday, September 4th. Phibro Animal Health’s payout ratio is currently 150.00%.

Insider Activity at Phibro Animal Health

In related news, Director E Thomas Corcoran acquired 5,000 shares of the firm’s stock in a transaction on Wednesday, September 4th. The stock was bought at an average cost of $20.02 per share, with a total value of $100,100.00. Following the acquisition, the director now directly owns 25,000 shares in the company, valued at $500,500. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 50.06% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on PAHC shares. JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price objective for the company. Bank of America increased their price target on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Friday, August 30th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, Phibro Animal Health has an average rating of “Hold” and a consensus target price of $15.00.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.